Cargando…

Dose-Dependent Effects of a Novel Selective EP(4) Prostaglandin Receptor Agonist on Treatment of Critical Size Femoral Bone Defects in a Rat Model

Difficulties in treating pseudarthrosis and critical bone defects are still evident in physicians’ clinical routines. Bone morphogenetic protein 2 (BMP-2) has shown promising osteoinductive results but also considerable side effects, not unexpected given that it is a morphogen. Thus, the bone regene...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vater, Corina, Mehnert, Elisabeth, Bretschneider, Henriette, Bolte, Julia, Findeisen, Lisa, Matuszewski, Lucas-Maximilian, Zwingenberger, Stefan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615441/ https://www.ncbi.nlm.nih.gov/pubmed/34829941 http://dx.doi.org/10.3390/biomedicines9111712

Ejemplares similares

Treatment of Critical-Size Femoral Bone Defects with Chitosan Scaffolds Produced by a Novel Process from Textile Engineering
por: Zwingenberger, Bruno, et al.
Publicado: (2021)

Treatment of Critical Size Femoral Bone Defects with Biomimetic Hybrid Scaffolds of 3D Plotted Calcium Phosphate Cement and Mineralized Collagen Matrix
por: Culla, Anna Carla, et al.
Publicado: (2022)

Cell spheroids are as effective as single cells suspensions in the treatment of critical-sized bone defects
por: Findeisen, Lisa, et al.
Publicado: (2021)

A facile one-stage treatment of critical bone defects using a calcium sulfate/hydroxyapatite biomaterial providing spatiotemporal delivery of bone morphogenic protein–2 and zoledronic acid
por: Raina, Deepak Bushan, et al.
Publicado: (2020)

Characterization of Naturally Occurring Bioactive Factor Mixtures for Bone Regeneration
por: Bretschneider, Henriette, et al.
Publicado: (2020)

Chemotactic and Angiogenic Potential of Mineralized Collagen Scaffolds Functionalized with Naturally Occurring Bioactive Factor Mixtures to Stimulate Bone Regeneration
por: Bretschneider, Henriette, et al.
Publicado: (2021)

Cytotoxicity of drugs injected into joints in orthopaedics
por: Busse, P., et al.
Publicado: (2019)

Cloning and expression of the rabbit prostaglandin EP2 receptor
por: Guan, Youfei, et al.
Publicado: (2002)

Regulation of prostaglandin EP(1) and EP(4) receptor signaling by carrier-mediated ligand reuptake
por: Chi, Yuling, et al.
Publicado: (2014)

Large-scale gene expression profiling data of bone marrow stromal cells from osteoarthritic donors
por: Stiehler, Maik, et al.
Publicado: (2016)

Inhibitory effects of prostaglandin EP(4 )receptors on human eosinophils
por: Luschnig-Schratl, Petra, et al.
Publicado: (2009)

Role of EP(2) and EP(4) receptors in airway microvascular leak induced by prostaglandin E(2)
por: Jones, Victoria C, et al.
Publicado: (2016)

T cell–intrinsic prostaglandin E(2)-EP2/EP4 signaling is critical in pathogenic T(H)17 cell–driven inflammation
por: Lee, Jinju, et al.
Publicado: (2019)

Screening of the Drug-Induced Effects of Prostaglandin EP2 and FP Agonists on 3D Cultures of Dexamethasone-Treated Human Trabecular Meshwork Cells
por: Watanabe, Megumi, et al.
Publicado: (2021)

The role of the EP receptors for prostaglandin E(2) in skin and skin cancer
por: Rundhaug, J. E., et al.
Publicado: (2011)

Prostaglandin E receptor 4 (EP4) promotes colonic tumorigenesis
por: Chang, Jian, et al.
Publicado: (2015)

Gene expression of prostaglandin EP4 receptor in three canine carcinomas
por: Musser, Margaret L., et al.
Publicado: (2020)

Prostaglandin E2/EP Signaling in the Tumor Microenvironment of Colorectal Cancer
por: Mizuno, Rei, et al.
Publicado: (2019)

Prostaglandin E2 receptor EP1 expression in vulvar cancer
por: Buchholz, Anna, et al.
Publicado: (2022)

Prostaglandin F2 and EP2 Agonists Exert Different Effects on 3D 3T3-L1 Spheroids during Their Culture Phase
por: Ida, Yosuke, et al.
Publicado: (2021)

Prostaglandin EP4 Selective Agonist AKDS001 Enhances New Bone Formation by Minimodeling in a Rat Heterotopic Xenograft Model of Human Bone
por: Ukon, Yuichiro, et al.
Publicado: (2022)

Prostaglandin E2 promotes human CD34(+) cells homing through EP2 and EP4 in vitro
por: Wang, Yaqun, et al.
Publicado: (2017)

Concerted EP2 and EP4 Receptor Signaling Stimulates Autocrine Prostaglandin E(2) Activation in Human Podocytes
por: Mangelsen, Eva, et al.
Publicado: (2020)

The prostaglandin receptor EP2 determines prognosis in EP3-negative and galectin-3-high cervical cancer cases
por: Dietlmeier, Sebastian, et al.
Publicado: (2020)

Accelerate postoperative management after scoliosis surgery in healthy and impaired children: intravenous opioid therapy versus epidural therapy
por: Dinter, Katharina, et al.
Publicado: (2021)

Prostaglandin receptors EP and FP are regulated by estradiol and progesterone in the uterus of ovariectomized rats
por: Blesson, Chellakkan S, et al.
Publicado: (2012)

Microglial inhibition of neuroprotection by antagonists of the EP1 prostaglandin E2 receptor
por: Carlson, Noel G, et al.
Publicado: (2009)

Role of the Prostaglandin E(2) EP1 Receptor in Traumatic Brain Injury
por: Glushakov, Alexander V., et al.
Publicado: (2014)

Heterodimerization of the prostaglandin E2 receptor EP2 and the calcitonin receptor CTR
por: Matsubara, Shin, et al.
Publicado: (2017)

Grapiprant: an EP4 prostaglandin receptor antagonist and novel therapy for pain and inflammation
por: Kirkby Shaw, Kristin, et al.
Publicado: (2015)

Evaluation of early medication persistence with omidenepag isopropyl, a topical selective prostaglandin EP2 agonist, in patients with glaucoma: a retrospective two-institute study
por: Nakakura, Shunsuke, et al.
Publicado: (2021)

Opposing effects of prostaglandin E(2) receptors EP3 and EP4 on mouse and human β-cell survival and proliferation
por: Carboneau, Bethany A., et al.
Publicado: (2017)

Characterization of the Signaling Modalities of Prostaglandin E2 Receptors EP2 and EP4 Reveals Crosstalk and a Role for Microtubules
por: Vleeshouwers, Ward, et al.
Publicado: (2021)

Establishment of a Segmental Femoral Critical-size Defect Model in Mice Stabilized by Plate Osteosynthesis
por: Manassero, Mathieu, et al.
Publicado: (2016)

Bone Healing of Critical-Sized Femoral Defects in Rats Treated with Erythropoietin Alone or in Combination with Xenograft
por: Vasileva, Radina, et al.
Publicado: (2023)

Orbital Fat Volume After Treatment with Topical Prostaglandin Agonists
por: Chen, Jessica Y., et al.
Publicado: (2020)

Sensitization of TRPV1 by EP(1 )and IP reveals peripheral nociceptive mechanism of prostaglandins
por: Moriyama, Tomoko, et al.
Publicado: (2005)

Facilitation of Th1-mediated immune response by prostaglandin E receptor EP1
por: Nagamachi, Miyako, et al.
Publicado: (2007)

A biological target for antiplatelet therapy: the prostaglandin E(2) receptor EP(4)
por: Philipose, Sonia, et al.
Publicado: (2010)

Prostaglandin E(2 )acts via the EP(4 )receptor to inhibit platelet aggregation
por: Philipose, Sonia, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_o3a25c7o6amu0kjol2sq5klb88